Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00256867 · ClinicalTrials.gov registry record · Phase 3
A Study In Patients With Type 2 Diabetes Mellitus
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 369
- Enrollment target
NCT00256867 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 369 participants.
The verdict
NCT00256867, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 369 participants
- Enrollment target
Study Summary
This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.
Interventions
- DRUG GSK523338
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2005-08-18 |
| Est. Completion | 2006-10-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00256867
The ClinicalTrials.gov registry entry for NCT00256867 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK523338 is the first listed.
NCT00256867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00256867 about?
NCT00256867 is a clinical study titled "A Study In Patients With Type 2 Diabetes Mellitus". This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.
What is the current status of trial NCT00256867?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 369 participants. The study started on 2005-08-18. Estimated completion is 2006-10-31.
What interventions are being tested in trial NCT00256867?
The interventions under investigation include: GSK523338 (DRUG).
Who is sponsoring clinical trial NCT00256867?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.